Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.
Press releases published on July 15, 2025
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
GlobeNewswire
·
July 15, 2025
Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technology Preclinical candidate data expected in early 2026, with …
Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
GlobeNewswire
·
July 15, 2025
- Alignment gained on Phase 2 inclusion/exclusion criteria, primary and secondary endpoints, and study design, including sample size and dosing regimen - Company expects to begin enrolling patients in Phase 2 in 2H 2025 SAN DIEGO and SUZHOU, China, July 15 …
AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
GlobeNewswire
·
July 15, 2025
AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutation CELESTE is informed by the STELLA prospective natural history study, which is currently enrolling …
Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting
GlobeNewswire
·
July 15, 2025
WALTHAM, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to be held …
Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer
GlobeNewswire
·
July 15, 2025
CHICAGO, July 15, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the promotion and appointment of James Leventis as the Company’s Chief …
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
GlobeNewswire
·
July 15, 2025
New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025 Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) …
Merakris Therapeutics Selected as Finalist for 2025 Advanced Would Care Summit Innovation Showcase
GlobeNewswire
·
July 15, 2025
RESEARCH TRIANGLE PARK, N.C., July 15, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics announces its amniotic fluid-derived regenerative biologic, MTX-001, an investigational new drug, is a finalist for the Innovation Showcase: Early-Stage Disruptors in …
Teladoc Health Launches Wellbound Employee Assistance Program (EAP)
GlobeNewswire
·
July 15, 2025
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program (EAP) designed to empower a more engaged, healthier workforce. The …
Award-Winning Actress and Advocate Terri J. Vaughn to Headline Inaugural Pennsylvania Maternal Health Summit
GlobeNewswire
·
July 15, 2025
Lancaster, Pennsylvania, July 15, 2025 (GLOBE NEWSWIRE) -- Acclaimed actress, producer, and maternal health advocate Terri J. Vaughn will serve as the keynote speaker for the first-ever Pennsylvania Maternal Health Summit, taking place Wednesday, August 6, …
4TEEN4 Announces Publication in European Journal of Heart Failure Demonstrating First-in-Human Shock Reversal Evidence for Procizumab in Three Compassionate Use Cases
GlobeNewswire
·
July 15, 2025
Data from three terminally ill cardiogenic shock patients showcase potential of procizumab to safely reverse shock within 48 hours and provide promising first-in-human evidence on the translatability of preclinical efficacy to humans Procizumab is a first- …
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
GlobeNewswire
·
July 15, 2025
Strong track record at executive and board level of building company value across all stages of development including supporting the development of multiple blockbuster medicines Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a …
Rakovina Therapeutics Granted DTC Eligibility to Expand U.S. Investor Access
GlobeNewswire
·
July 15, 2025
VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
Nixol Capsules Arrive in the UK: Harnessing Nature to Transform Weight Loss & Metabolic Health
GlobeNewswire
·
July 15, 2025
London, UK, July 15, 2025 (GLOBE NEWSWIRE) -- Nixol a plant-powered metabolic support supplement, is now available to individuals across the United Kingdom. Formulated to help those struggling with weight control and a sluggish metabolism, Nixol Capsules …
Topflight Pharma Development Veteran Joins Synendos
GlobeNewswire
·
July 15, 2025
BASEL, Switzerland, July 15, 2025 (GLOBE NEWSWIRE) -- Synendos Therapeutics (“Synendos”), the clinical-stage biotechnology company developing breakthrough therapies for neuropsychiatric disorders, announced today that it has named Dr. George Garibaldi, CMO …
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
GlobeNewswire
·
July 15, 2025
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation …